SugarCRM Named to Constellation ShortList for Top Midmarket CRM Suites
The Constellation ShortList™ portfolio highlights the key players when considering technology investments in key areas and is designed to provide guidance on rapidly changing requirements and customer needs and demands.
The Midmarket CRM Suites ShortList was compiled based on Constellation client inquiries, partner conversations, customer references, vendor selection projects, market share and internal research.
Constellation defines midmarket organizations as those that typically have from 250 to 1,000 employees and generate between $250 million and $1 billion in annual revenues. According to the research, in the midmarket CRM space, buyers typically seek one or more products in a suite to support sales force automation, service and support, marketing solutions, and commerce capabilities. Buyers expect analytics to be pervasive, integrated, and easy to use.
Sugar Sell, sales-i, Market, and Serve are all part of SugarCRM's platform designed to unify sales, marketing and service through intuitive AI-powered capabilities. Together, these solutions break down the silos that often exist within a business, ensuring a cohesive and efficient approach to customer relationship management and customer success.
'This Constellation ShortList recognizes the strengths of our AI-powered CRM platform,' said David Roberts, SugarCRM Chief Executive Officer. 'Today's organizations demand more than data and insights; they want CRM solutions to direct sellers and customer-facing teams to the right next steps. Sugar delivers AI-powered sales technology that simplifies the complexity that comes from hundreds of customers and thousands of products, improving the productivity and effectiveness of a typical seller.'
'As AI reshapes the business landscape, organizations are under increasing pressure to realize meaningful transformation,' said R 'Ray' Wang, CEO and Founder at Constellation Research. 'In this era of accelerated change, Constellation's ShortList is designed to help companies identify top-performing solutions that drive efficiency and innovation.'
Click here to learn more about Sugar's AI-driven solutions for CRM.
About the Constellation ShortList
Constellation Research advises leaders on leveraging disruptive technologies to achieve business model transformation and streamline business processes. Products and services named to the Constellation ShortList meet the threshold criteria for this category as determined through client inquiries, partner conversations, customer references, vendor selection projects, market share, and internal research. The portfolio is updated at least once per year as the analyst team deems necessary based on market conditions.
Disclaimer: Constellation Research does not endorse any solution or service named in its research.
About SugarCRM
SugarCRM offers software solutions that help marketing, sales, and service teams reach peak efficiency through better automation, data, and intelligence so they can achieve a real-time, reliable view of each customer. Sugar's platform provides leading technology in the sales automation, marketing automation, and customer service fields with one goal in mind: to make the hard things easier.
Thousands of companies in over 120 countries rely on Sugar by letting the platform do the work. Headquartered in the San Francisco Bay Area, Sugar is backed by Accel-KKR.
For more information about SugarCRM, visit: www.sugarcrm.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
3 hours ago
- Business Wire
VIQ Solutions Posts Fifth Straight Positive Adjusted EBITDA Quarter
MISSISSAUGA, Ontario--(BUSINESS WIRE)--VIQ Solutions Inc. ('VIQ' or 'the Company') (TSX: VQS), a global leader in AI-powered digital documentation, today announced financial results for the three and six months ended June 30, 2025. The Company reported continued margin expansion, its fifth consecutive quarter of positive Adjusted EBITDA, and secured its largest SaaS deployment to date, reinforcing its leadership in secure, evidence-based transcription for regulated sectors. Second Quarter 2025 Financial Highlights Revenue: $10.4 million, decrease of 10%, from the same period in the prior year, reflecting the timing of customer volumes and market conditions. Gross Margin: 48%, up from 45.5% from the same period in the prior year, driven by automation and productivity gains. Adjusted EBITDA: $1 million, increase of $0.2 million or 24% from the same period in the prior year, marking the fifth consecutive quarter of positive results. Adjusted Operating Loss: $0.8 million, compared to $0.6 million from the same period in the prior year. First Half 2025 Financial Highlights Revenue: $20 million, decrease of 7%, from the same period in the prior year, reflecting the timing of customer volumes and market conditions. Gross Margin: Nearly 50%, up from 44.9% from the same period in the prior year, driven by automation and productivity gains. Adjusted EBITDA: $1.8 million, increase of $1.1 million or 164% from the same period in the prior year, reflecting sustained cost discipline and efficiency gains. Adjusted Operating Loss: $1.5 million, an improvement of $0.9 million. Strategic and Operational Highlights Landmark SaaS Court Deployment: In July 2025, VIQ secured its largest SaaS engagement to date, implementing NetScribe® across 9 judicial districts and 22 counties in the U.S. Midwest. This milestone accelerates VIQ's transition to a higher-margin, subscription-based revenue model. AI-Driven Workflow Automation: The deployment integrates NetScribe®, aiAssist™, Advanced Formatter, supporting internally produced transcription with scalability and optional add-ons including domain-specific language models, advanced post-processing rules, multilingual support, and automated summarization. First Half 2025 Organic Bookings Momentum: VIQ secured $1.9 million of new bookings during first half of 2025, supporting ongoing gross margin expansion and strengthening long-term free cash flow prospects. Management Commentary 'In the first half of 2025, VIQ delivered 164% growth in Adjusted EBITDA, expanded gross margins to nearly 50%, and achieved our fifth consecutive quarter of positive EBITDA,' said Alexie Edwards, CFO of VIQ Solutions. 'While we reported a net loss, this includes approximately $2.0 million in non-cash expenses, such as depreciation, amortization, and stock-based compensation, with $1.1 million recorded in Q2. These charges impact earnings per share but do not affect our cash flow.' 'With our largest SaaS deployment now in motion, increased bookings, and a clear focus on strengthening the balance sheet and reducing debt, we are expanding our financial flexibility to reinvest in growth. Our AI-driven platform and automation strategy continue to fuel stronger margins and sustained EBITDA gains, laying the foundation for long-term growth and value creation.' A copy of the Company's unaudited financial statements and accompanying MD&A for the three and six months ended June 30, 2025 (collectively, the 'Financial Information') will be available under the Company's profile on SEDAR+ at Conference Call Details VIQ will host a conference call and webcast to discuss Financial Information on August 14, 2025, at 11:00 a.m. (Eastern time). The call will consist of updates by Alexie Edwards, VIQ's Chief Financial Officer followed by a question-and-answer period. Investors may access a live webcast of the call on the Company's website at or by dialing 1-888-440-4052 (North America toll-free) or +1-646-960-0827 (international) to be connected to the call by an operator using conference ID number 4983233. Participants should dial at least 10 minutes before the call starts. A replay of the webcast will be available on the Company's website through the same link approximately one hour after the conference call concludes. For more information about VIQ, please visit About VIQ Solutions VIQ Solutions is a global provider of secure, AI-driven, digital voice and video capture technology and transcription services. VIQ offers a seamless, comprehensive solution suite that delivers intelligent automation, enhanced with human review, to drive transformation in the way content is captured, secured, and repurposed into actionable information. The cyber-secure, AI technology and services platform are implemented in the most rigid security environments including criminal justice, legal, insurance, government, corporate finance, media, and transcription service provider markets, enabling them to improve the quality and accessibility of evidence, to easily identify predictive insights and to achieve digital transformation faster and at a lower cost. Forward-looking Statements Certain statements included in this press release constitute forward-looking statements or forward-looking information (collectively, 'forward-looking statements') under applicable securities legislation. Such forward-looking statements or information are provided for the purpose of providing information about management's current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes. Forward-looking statements typically contain statements with words such as 'anticipate', 'believe', 'expect', 'plan', 'intend', 'estimate', 'propose', 'project' or similar words, including negatives thereof, suggesting future outcomes or that certain events or conditions 'may' or 'will' occur. These statements are only predictions. Forward-looking statements in this press release include but are not limited to statements with respect to the Company's ability to accelerate automation, optimize costs, and improve scalability in the future, expected margin improvement, the Company's focus and its priorities, the filing of the Financial Information on SEDAR+ and the conference call to discuss the Company's financial results. Forward-looking statements are based on several factors and assumptions which have been used to develop such statements, but which may prove to be incorrect. Although VIQ believes that the expectations reflected in such forward-looking statements are reasonable, undue reliance should not be placed on forward-looking statements because VIQ can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding, among other things, recent initiatives, cost savings from workforce and product optimization, cost reductions from the Company's workflow solutions and that sales and prospects may increase revenue. Readers are cautioned that the foregoing list is not exhaustive of all factors and assumptions that have been used. Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that while considered reasonable by the Company as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements, including but not limited to the factors described in greater detail in the 'Risk Factors' section of the Company's annual information form and in the Company's other materials filed with the Canadian securities regulatory authorities. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. Such estimates and assumptions may prove to be incorrect or overstated. The forward-looking statements contained in this press release are made as of the date of this press release and the Company expressly disclaims any obligations to update or alter such statements, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law. Non-IFRS Measures The Company prepares its financial statements in accordance with IFRS. Non-IFRS measures are provided by management to provide additional insight into our performance and financial condition. VIQ believes non-IFRS measures are an important part of the financial reporting process and are useful in communicating information that complements and supplements the consolidated financial statements. Adjusted EBITDA and adjusted operating loss are not measures recognized by IFRS and do not have a standardized meanings prescribed by IFRS. Therefore, Adjusted EBITDA and adjusted operating loss may not be comparable to similar measures presented by other issuers. Investors are cautioned that Adjusted EBITDA and adjusted operating loss should not be construed as alternatives to net income (loss) as determined in accordance with IFRS. For a reconciliation of net income (loss) to Adjusted EBITDA and adjusted operating loss please see the Company's MD&A for three and six months ended June 30, 2025. To evaluate the Company's operating performance as a complement to results provided in accordance with IFRS, the term 'Adjusted EBITDA' refers to net income (loss) before adjusting earnings for stock-based compensation, depreciation, amortization, interest expense, accretion, and other financing expense, (gain) loss on revaluation of options, (gain) loss on revaluation of restricted share units, gain (loss) on revaluation of derivative warrant liability, restructuring costs, strategic review costs, loss on modification of debt, impairment of property and equipment, impairment of goodwill and intangibles, other expense (income), foreign exchange (gain) loss, current and deferred income tax expense. We believe that the items excluded from Adjusted EBITDA are not connected to and do not represent the operating performance of the Company. We believe that Adjusted EBITDA is useful supplemental information as it provides an indication of the results generated by the Company's main business activities prior to taking into consideration how those activities are financed and taxed as well as expenses related to stock-based compensation, depreciation, amortization, impairment of goodwill and intangibles, loss on modification or extinguishment of debt, other expense (income), and foreign exchange (gain) loss. Accordingly, we believe that this measure may also be useful to investors in enhancing their understanding of the Company's operating performance. The term 'adjusted operating loss' refers to net income (loss) excluding the impact of strategic review costs. Management believes it is appropriate to adjust for this item because strategic review costs do not relate to operating activities of the Company and is useful supplemental information as it provides an indication of the results generated by the Company's main business activities. The presentation of this measure enables investors and analysts to better understand the underlying performance of our business activities. We calculate 'bookings' for a given period as the estimated contract value (for services tied to volume) of our recurring client contracts entered into during the period from (i) new clients and (ii) net upgrades by existing clients within the same workload, plus the actual (not annualized) estimated value of professional services consulting, advisory or project-based orders received, software licenses, subscriptions, SaaS, and hardware during the period. Trademarks This press release includes trademarks, such as 'NetScribe', which are protected under applicable intellectual property laws and are the property of VIQ. Solely for convenience, our trademarks referred to in this press release may appear without the ® or TM symbol, but such references are not intended to indicate, in any way, that we will not assert our rights to these trademarks, trade names, and services marks to the fullest extent under applicable law. Trademarks that may be used in this press release, other than those that belong to VIQ, are the property of their respective owners. VIQ Solutions Inc. Interim Condensed Consolidated Statements of Loss and Comprehensive Loss (Expressed in US dollars, unaudited) Three months ended June 30, Six months ended June 30, 2025 2024 2025 2024 Revenue $ 10,445,488 $ 11,575,614 $ 20,024,513 $ 21,497,287 Cost of sales 5,436,220 6,312,797 10,040,105 11,841,912 Gross profit 5,009,268 5,262,817 9,984,408 9,655,375 Expenses Selling and administrative expenses 3,866,110 4,328,687 7,676,752 8,639,461 Research and development expenses 179,957 155,416 320,476 320,526 Stock-based compensation 292,682 111,283 291,865 139,816 Gain on revaluation of RSUs (21,482 ) (18,534 ) (19,553 ) (47,311 ) Loss (gain) on revaluation of the derivative Warrant liability 8,260 7,479 1,238 (49,686 ) Foreign exchange gain (354,295 ) (590,719 ) (438,327 ) (487,886 ) Depreciation 175,864 194,237 340,547 389,221 Amortization 658,581 813,889 1,366,158 1,620,346 Interest expense 439,704 405,965 928,326 794,889 Accretion and other financing costs 456,029 425,216 875,059 752,094 Restructuring costs (recovery) 37,349 5,874 36,066 (3,820 ) Strategic review costs 119,124 – 1,294,726 – Other income (1,911 ) (10,208 ) (8,118 ) (21,413 ) Total expenses 5,855,972 5,828,585 12,665,215 12,046,237 Current income tax expense 52,654 6,063 86,933 21,107 Income tax expense 52,654 6,063 86,933 21,107 Net loss for the period $ (899,358 ) $ (571,831 ) $ (2,767,740 ) $ (2,411,969 ) Exchange (loss) gain on translation of foreign operations 16,115 (483,076 ) 15,027 (795,107 ) Comprehensive loss for the period $ (883,243 ) $ (1,054,907 ) $ (2,752,713 ) $ (3,207,076 ) Net loss per share Basic (0.02 ) (0.01 ) (0.05 ) (0.05 ) Diluted (0.02 ) (0.01 ) (0.05 ) (0.05 ) Weighted average number of common shares outstanding – basic 52,563,142 51,348,578 52,449,214 48,065,488 Weighted average number of common shares outstanding – diluted 52,563,142 51,348,578 52,449,214 48,065,488 Expand The following is a reconciliation of Net Loss to Adjusted EBITDA, the most directly comparable IFRS measure for the three and six months ended June 30, 2025, and 2024: The following is a reconciliation of Net Loss to Adjusted operating loss, the most directly comparable IFRS measure for the three and six months ended June 30, 2025, and 2024:
Business Wire
6 hours ago
- Business Wire
Adagio Medical Reports Second Quarter 2025 Results
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ('Adagio' or 'the Company'), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the second quarter ended June 30, 2025. Recent Business Highlights: Surpassed 85% enrollment in the FULCRUM-VT pivotal study of the Company's vCLAS™ Cryoablation System. The study, which seeks to enroll 206 patients with either ischemic or non-ischemic drug-refractory, recurrent, sustained monomorphic ventricular tachycardia ('VT') at 20 U.S. and Canadian centers, is on track for completion of patient enrollment in the second half of 2025 First-in-human results from the PARALELL study, which evaluated the safety and effectiveness of Adagio's Pulsed Field Cryoablation ('PFCA'), a novel, dual-energy cardiac ablation modality combining Pulsed Field Ablation (PFA) with Adagio's proprietary Ultra-Low Temperature Cryoablation ('ULTC'), were published in the Journal of Cardiovascular Electrophysiology Reduced cash burn quarter-over-quarter as a result of the Company's corporate prioritization initiative, which streamlined operations and focused resources on highest-value programs 'In the second quarter we saw continued strong momentum in the enrollment of our FULCRUM-VT study, which we believe validates the market need for our purpose-built technology and brings us one step closer to offering our proprietary ULTC solutions to patients in the United States who suffer from ventricular tachycardia,' said Todd Usen, Chief Executive Officer of Adagio. 'The team also made meaningful progress in advancing our pipeline through the continued development of our next-generation product, which is designed to improve usability for physicians while further enhancing the capabilities of our differentiated ULTC platform.' Second Quarter 2025 Financial Results Cost of revenue was $0.3 million for the three months ended June 30, 2025, compared to $0.7 million for the three months ended June 30, 2024. Research and development expenses were $2.0 million for the three months ended June 30, 2025 compared to $2.9 million for the three months ended June 30, 2024 Selling, general and administrative expenses were $2.4 million for the three months ended June 30, 2025, compared to $3.4 million for the three months ended June 30, 2024. Net loss for the three months ended June 30, 2025, was $3.9 million, or $(0.26) per share (Basic), compared to a net loss of $5.7 million, or $(7.35) per share (Basic), for the three months ended June 30, 2024. Reported cash and cash equivalents of $8.2 million as of June 30, 2025. About Adagio Medical Holdings, Inc. Adagio is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology. ULTC is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Company is currently focused on the treatment of ventricular tachycardia (VT) with its purpose-built vCLAS™ Cryoablation System, which is CE Marked and is currently under evaluation in the Company's FULCRUM-VT U.S. IDE Pivotal Study. About FULCRUM VT FULCRUM-VT (Feasibility of Ultra-Low Temperature Cryoablation in Recurring Monomorphic Ventricular Tachycardia) is a prospective, multi-center, open-label, single-arm study, enrolling 206 patients with structural heart disease of both ischemic and non-ischemic cardiomyopathy, indicated for catheter ablation of drug refractory VT in accordance with current treatment guidelines. The results of the study will be used to apply for FDA premarket approval (PMA) for Adagio's vCLAS™ Cryoablation System, potentially leading to the broadest industry indication for purely endocardial ablation of scar-mediated VT. Adagio's vCLAS™ Cryoablation System is commercially available for the treatment of monomorphic ventricular tachycardia in Europe and select other geographies but is limited to investigational use in the United States. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as 'anticipates,' 'believes,' 'expects,' 'intends,' 'projects,' 'plans,' and 'future' or similar expressions are intended to identify forward-looking statements. Forward-looking statements include statements concerning: the potential of Adagio's vCLAS™ Cryoablation System; Adagio's research, development and regulatory plans for its product candidates, including the timing of initiating additional trials and reporting data from its trials; the ability of Adagio to bring its proprietary ULTC solutions to patients in the United States who suffer from VT and their ability to improve usability for physicians; the potential for its product candidates to receive regulatory approval from the FDA or equivalent foreign regulatory agencies; and its current cash resources and the impacts of its corporate prioritization initiative and realignment of resources. Forward-looking statements are based on management's current expectations and are subject to various risks and uncertainties that could cause actual results to differ materially and adversely from those expressed or implied by such forward-looking statements. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding Adagio's business are described in detail in Adagio's Securities and Exchange Commission ('SEC') filings, including in its Annual Report on Form 10-K for the full-year ended December 31, 2024, which is available on the SEC's website at Additional information will be made available in other filings that Adagio makes from time to time with the SEC. These forward-looking statements speak only as of the date hereof, and Adagio disclaims any obligation to update these statements except as may be required by law.
Business Wire
8 hours ago
- Business Wire
Wiland Expands MarketSignals™ Platform with Powerful New Brand and Category Signals Capabilities
NIWOT, Colo.--(BUSINESS WIRE)--Wiland, Inc., a leading provider of marketing data and predictive intelligence, today announced the addition of brand and category signals to its rapidly expanding MarketSignals™ platform. This new release brings powerful brand- and category-level insights to marketers seeking to optimize their strategies, conquer competitive challenges, and unlock growth across verticals such as retail, travel, dining, insurance, and more. 'With brand and category signals, we're giving marketers the clearest view yet into what drives consumer choice—insight that transforms targeting, retention, and growth strategies.' — Mike Gingell, CEO, Wiland Share Built from Wiland's immense consumer spending data—comprised of actual transactions from over 80 million individuals—brand and category signals deliver predictive signals for more than 220 top consumer brands and product categories. This expansion introduces granular, brand-specific elements such as purchase propensity, loyalty score, and lifetime value, giving marketers an unprecedented understanding of how their best customers—and their competitors'—behave across the marketplace. Wiland is adding new signals every two weeks and expects to increase coverage to over 500 brands and categories by the end of the year. 'With brand and category signals, we're empowering marketers with the clearest view yet of what drives consumer choice at the brand level,' said Mike Gingell, CEO of Wiland. 'This isn't just about knowing if someone is likely to shop at a specific retailer—it's about understanding the depth of that relationship, whether they're loyal, infrequent, or part of the moveable middle. These signals are transformative for marketers looking to personalize outreach, reduce churn, and drive smarter growth decisions.' Modeled from trillions of dollars in actual spend data, brand and category signals offer predictive insights in key behavioral dimensions—recency, frequency, and monetary value—across both brands and categories. These signals reveal: Who is buying from which brands How often they make purchases How loyal they are—or are not Whether they're currently in-market How much they are likely to spend over time Use cases range from uncovering brand conquesting opportunities and identifying competitive pressures, to segmenting audiences by customer value and loyalty. For example, a major brand can use brand and category signals to understand which of its loyal customers are shopping at competitors—or discover partnership opportunities through adjacencies. Unlike panels or opt-in loyalty data that reflect small slivers of consumer behavior, brand and category signals deliver insights across a vast, modeled universe of actual buyers. It enables brands to eliminate reliance on incomplete or unmatchable raw data and instead integrate high-performing predictive models directly into their analytics and AI systems. MarketSignals, which now includes FanSignals™, GivingSignals™, and TravelSignals™, continues to offer the most comprehensive and actionable view of consumer behavior across the U.S. economy. Every signal is built through Wiland's proprietary, fully automated modeling platform that assembles and refines data inputs with unmatched speed, precision, and scale. To learn more about Brand and category signals or the MarketSignals platform, visit ABOUT WILAND, INC. Wiland, Inc. is the marketing data and audiences company that leading brands and nonprofit organizations trust to help them develop and maintain robust customer and donor relationships that produce higher revenue, less advertising waste, and more profit. Wiland's data and audience products are informed by the largest set of detailed, individual-level spending signals ever assembled. The company's AI-enabled response prediction platform analyzes this vast information to deliver powerful insights and solutions that drive success across all addressable marketing channels. For more information about Wiland, visit
